Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research note published on Monday morning. The firm issued a buy rating on the stock.

Mannatech Stock Performance

Shares of MTEX opened at $8.13 on Monday. Mannatech has a 12 month low of $6.75 and a 12 month high of $10.51. The stock has a fifty day moving average price of $7.75 and a 200-day moving average price of $7.54. The company has a current ratio of 1.25, a quick ratio of 0.62 and a debt-to-equity ratio of 0.44. The firm has a market cap of $15.32 million, a PE ratio of -10.03 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The business had revenue of $31.73 million for the quarter.

Insider Activity

In related news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now owns 54,721 shares in the company, valued at $424,087.75. This trade represents a 22.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.